Stock & Company Details
Curis Inc $CRIS
Price:
N/A
N/A
2.1M
$1.7M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.06
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CRIS technical indicators
Latest Curis Inc (CRIS) indicator readings as of 2026-10-09.
CRIS's 14-day RSI is 15.2, in oversold territory. At $0.67 it is trading 50.9% below its 200-day moving average of $1.37, and below its 50-day average of $1.70. Price sits near the lower Bollinger Band ($0.61 to $1.18). ADX reads 53.8, indicating a trending market.
Overview
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Finance Bot
Ask your questions
Start by typing a question below.
